Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Targeting Intracellular Signaling Cascades for Patients with Relapsed, Refractory Multiple Myeloma: A Systematic Review of Clinical Trials

Shehroz Aslam, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Rida Riaz, MBBS, Seren Durer, MD, Ceren Durer, MD, Faisal Mahfooz, MD, Muhammad Jahanzeb Khalil, MD, Jemin Aby Jose, MD, Zunairah Shah, MBBS, Chaudhry Saad Sohail, MD, Maaz Ahmed Yusufi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5659.

https://doi.org/10.1182/blood-2018-99-115721

Published: 2018

Journal Articles

Efficacy of Bortezomib Based Regimens and Disease Monitoring in Light Chain Multiple Myeloma: A Review of Literature

Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Shehroz Aslam, MD, Rida Riaz, MBBS, Seren Durer, MD, Ceren Durer, MD, Muhammad Abu Zar, MD, Zunairah Shah, MBBS, Ahmad Kamal, MD, Anum Qureshi, Jemin Aby Jose, MD, Insija Ilyas Selene, MBBS, Faiza Jamil, MD, Madeeha Shafqat, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5624.

https://doi.org/10.1182/blood-2018-99-109921

Published: 2018

Journal Articles

Efficacy and Safety Profile of Novel Alkylators in Combination Regimens for Patients with Multiple Myeloma: A Review of Literature

Shehroz Aslam, MD, Rida Riaz, MBBS, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Jemin Aby Jose, MD, Zunairah Shah, MBBS, Muhammad Abu Zar, MD, Anum Qureshi, Ahmad Kamal, MD, Awais Ijaz, MD, Ali Younas Khan, MD, Saad Ullah Malik, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5626.

https://doi.org/10.1182/blood-2018-99-110144

Published: 2018

Journal Articles

Efficacy and Safety of Newer Targeted Immunotherapy for Multiple Myeloma

Shehroz Aslam, MD, Rida Riaz, MBBS, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Warda Faridi, MD, Saad Ullah Malik, MD, Insija Ilyas Selene, MBBS, Zunairah Shah, MBBS, Chaudhry Saad Sohail, MD, Faisal Mahfooz, MD, Sharoon Samuel, MBBS, Muhammad Yasir, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5650.

https://doi.org/10.1182/blood-2018-99-110233

Published: 2018

Journal Articles

Promising Clinical Efficacy and Toxicity Profile of Isatuximab Based Regimens for Treatment of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: A Systematic Review

Zunairah Shah, MBBS, Madeeha Shafqat, Faiza Jamil, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Shehroz Aslam, MD, Anum Qureshi, Maryam Sadiq, MBBS, Muhammad Abu Zar, MD, Ahmad Kamal, MD, Insija Ilyas Selene, MBBS, Sharoon Samuel, MBBS, Rida Riaz, MBBS, Midhat Lakhani, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1949.

https://doi.org/10.1182/blood-2018-99-110243

Published: 2018

Journal Articles

Clinical Efficacy of Intracellular Molecular Inhibitors for Relapsed, Refractory Multiple Myeloma: A Systematic Review of Early Clinical Data

Shehroz Aslam, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Rida Riaz, MBBS, Muhammad Jahanzeb Khalil, MD, Faisal Mahfooz, MD, Madeeha Shafqat, Anum Qureshi, Insija Ilyas Selene, MBBS, Syed Shabee Hassan, MD, Muhammad Junaid Tariq, MD, Muhammad Yasir, MD, Sharoon Samuel, MBBS, Maryam Sadiq, MBBS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1950.

https://doi.org/10.1182/blood-2018-99-111587

Published: 2018

NARROW

Targeting Intracellular Signaling Cascades for Patients with Relapsed, Refractory Multiple Myeloma: A Systematic Review of Clinical Trials

Efficacy of Bortezomib Based Regimens and Disease Monitoring in Light Chain Multiple Myeloma: A Review of Literature

Efficacy and Safety Profile of Novel Alkylators in Combination Regimens for Patients with Multiple Myeloma: A Review of Literature

Efficacy and Safety of Newer Targeted Immunotherapy for Multiple Myeloma

Promising Clinical Efficacy and Toxicity Profile of Isatuximab Based Regimens for Treatment of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: A Systematic Review

Clinical Efficacy of Intracellular Molecular Inhibitors for Relapsed, Refractory Multiple Myeloma: A Systematic Review of Early Clinical Data

Email alerts

ASH Publications

American Society of Hematology

Targeting Intracellular Signaling Cascades for Patients with Relapsed, Refractory Multiple Myeloma: A Systematic Review of Clinical Trials

Efficacy of Bortezomib Based Regimens and Disease Monitoring in Light Chain Multiple Myeloma: A Review of Literature

Efficacy and Safety Profile of Novel Alkylators in Combination Regimens for Patients with Multiple Myeloma: A Review of Literature

Efficacy and Safety of Newer Targeted Immunotherapy for Multiple Myeloma

Promising Clinical Efficacy and Toxicity Profile of Isatuximab Based Regimens for Treatment of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: A Systematic Review

Clinical Efficacy of Intracellular Molecular Inhibitors for Relapsed, Refractory Multiple Myeloma: A Systematic Review of Early Clinical Data

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only